Hope Bancorp (NASDAQ:HOPE) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.45 by 4.44 percent. This is unchanged from the same period last year.
Apollomics Announces Two New Cohorts In Global Phase 2 SPARTA Study Of Vebreltinib In Non-Small Cell Lung Cancer And Other Solid Tumors With MET Dysregulation
The first new cohort, labeled C-2, is evaluating the addition of vebreltinib to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, such as osimertinib, for patients with EGFR-mutated NSCLC progressing on
